JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Approval Id: 1b3084cea501d7bd
Drug Approval Canada Name: JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Product Name: JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Status: Marketed
Status Date: 2022-12-14
Original Market Date: 2022-12-14
Din: 02519461
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.16
Atc Original: J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ
Atc Name: j 05 ar 06
Aig Number: 0352327001
Company Name: Jamp Pharma Corporation
Company Address: 1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path: /organization/jamp-pharma-corporation

EFAVIRENZ

600 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

EMTRICITABINE

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1b3084cea501d7bd

Type

Standard